Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

CLRB - Cellectar Biosciences, Inc. Financial... | Finranks

Home

/

CLRB

C

Cellectar Biosciences, Inc. (CLRB)

NCM – Real Time Price. Currency in USD

2.63

-0.02 (-0.75%)

Market open: Aug 12, 2026, 10:00 AM EDT

2.65

+0.01 (0.38%)

Previous after-hours: Aug 11, 2026, 7:56 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

0

0

0

Cost of goods sold

-214K

-292K

-192K

-148K

Gross Profit

-214K

-292K

-192K

-148K

Operating expenses (excl. COGS)

-23M

-51M

-39M

-29M

Operating Income

-23M

-52M

-39M

-29M

Non-operating income, total

1M

7M

-4M

-3M

Pretax income

-22M

-45M

-43M

-32M

Equity in earnings

0

0

0

0

Taxes

0

-66K

60K

60K

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-22M

-45M

-43M

-32M

Discontinued operations

0

0

0

0

Net income

-22M

-45M

-43M

-32M

Dilution adjustment

0

-7M

0

0

Preferred dividends

-

-

-

0

Name

2025

2024

2023

2022

Total assets

15M-41.2%

25M+111.0%

12M-44.1%

22M

Total current assets

14M

24M

10M

21M

Total non-current assets

940K

1M

2M

1M

Total liabilities

5M-48.4%

10M-62.1%

26M+114.5%

12M

Total current liabilities

5M

9M

25M

12M

Total non-current liabilities

309K

410K

494K

553K

Total equity

10M

16M

-14M

10M

Total liabilities & shareholders' equities

15M

25M

12M

22M

Total debt

410K-17.1%

494K-10.7%

553K-8.4%

604K

Name

2025

2024

2023

2022

Cash from operating activities

-23M

-48M

-32M

-25M

Cash from investing activities

-6K

-104K

-864K

-226K

Cash from financing activities

13M

61M

23M

10M

Free cash flow

-23M+51.5%

-48M-43.5%

-33M-30.6%

-25M